IGF2BP3 and neoplasm: Studies have shown that in colorectal cancer, IGF2BP3 modulates the expression of T cell chemokines such as CCL5 and CXCL9/10, thereby influencing T cell recruitment to the tumor site (Yang et al., 2020).